Established in 1993, the CBS is a research center dedicated to structural biology, biophysics, and bioengineering, at the interface of biology, chemistry, and physics.
Its mission is to understand the physicochemical mechanisms underlying biological processes, from the molecular and cellular levels to supramolecular assemblies in living organisms. The CBS is jointly supported by Inserm, CNRS, and the University of Montpellier.
It hosts advanced scientific services and methodological platforms, open to the wider scientific community and accredited by IBISA.
In addition to structural biology (cryo-EM, crystallography, NMR, SAXS, structural bioinformatics) and biophysical characterization (ITC, CD, TSA, BLI, DLS, SEC-MALS, nanoDSF) of proteins and biomolecular complexes, the CBS provides expertise in (i) the design and screening of de novo protein binders and (ii) the screening of fragments for drug design.
